Literature DB >> 32203679

CRISPR-Edited Immune Effectors: The End of the Beginning.

Feiyan Mo1, Helen E Heslop2, Maksim Mamonkin2.   

Abstract

Mesh：

Year:  2020        PMID： 32203679      PMCID： PMC7132620          DOI： 10.1016/j.ymthe.2020.03.009

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  Identification of preexisting adaptive immunity to Cas9 proteins in humans.

Authors:  Carsten T Charlesworth; Priyanka S Deshpande; Daniel P Dever; Joab Camarena; Viktor T Lemgart; M Kyle Cromer; Christopher A Vakulskas; Michael A Collingwood; Liyang Zhang; Nicole M Bode; Mark A Behlke; Beruh Dejene; Brandon Cieniewicz; Rosa Romano; Benjamin J Lesch; Natalia Gomez-Ospina; Sruthi Mantri; Mara Pavel-Dinu; Kenneth I Weinberg; Matthew H Porteus
Journal:  Nat Med       Date:  2019-01-28       Impact factor: 53.440

Review 2.  Tumor Antigen Escape from CAR T-cell Therapy.

Authors:  Robbie G Majzner; Crystal L Mackall
Journal:  Cancer Discov       Date:  2018-08-22       Impact factor: 39.397

3.  Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

Authors:  Laurent Poirot; Brian Philip; Cécile Schiffer-Mannioui; Diane Le Clerre; Isabelle Chion-Sotinel; Sophie Derniame; Pierrick Potrel; Cécile Bas; Laetitia Lemaire; Roman Galetto; Céline Lebuhotel; Justin Eyquem; Gordon Weng-Kit Cheung; Aymeric Duclert; Agnès Gouble; Sylvain Arnould; Karl Peggs; Martin Pule; Andrew M Scharenberg; Julianne Smith
Journal:  Cancer Res       Date:  2015-07-16       Impact factor: 12.701

4.  Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.

Authors:  Jiangtao Ren; Xiaojun Liu; Chongyun Fang; Shuguang Jiang; Carl H June; Yangbing Zhao
Journal:  Clin Cancer Res       Date:  2016-11-04       Impact factor: 12.531

5.  TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.

Authors:  Laurie Menger; Anna Sledzinska; Katharina Bergerhoff; Frederick Arce Vargas; Julianne Smith; Laurent Poirot; Martin Pule; Javier Hererro; Karl S Peggs; Sergio A Quezada
Journal:  Cancer Res       Date:  2016-04-15       Impact factor: 12.701

6.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

7.  CRISPR-engineered T cells in patients with refractory cancer.

Authors:  Edward A Stadtmauer; Joseph A Fraietta; Simon F Lacey; Carl H June; Megan M Davis; Adam D Cohen; Kristy L Weber; Eric Lancaster; Patricia A Mangan; Irina Kulikovskaya; Minnal Gupta; Fang Chen; Lifeng Tian; Vanessa E Gonzalez; Jun Xu; In-Young Jung; J Joseph Melenhorst; Gabriela Plesa; Joanne Shea; Tina Matlawski; Amanda Cervini; Avery L Gaymon; Stephanie Desjardins; Anne Lamontagne; January Salas-Mckee; Andrew Fesnak; Donald L Siegel; Bruce L Levine; Julie K Jadlowsky; Regina M Young; Anne Chew; Wei-Ting Hwang; Elizabeth O Hexner; Beatriz M Carreno; Christopher L Nobles; Frederic D Bushman; Kevin R Parker; Yanyan Qi; Ansuman T Satpathy; Howard Y Chang; Yangbing Zhao
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

8.  Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells.

Authors:  Pamela M Odorizzi; Kristen E Pauken; Michael A Paley; Arlene Sharpe; E John Wherry
Journal:  J Exp Med       Date:  2015-06-01       Impact factor: 14.307

9.  High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Authors:  Benjamin P Kleinstiver; Vikram Pattanayak; Michelle S Prew; Shengdar Q Tsai; Nhu T Nguyen; Zongli Zheng; J Keith Joung
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

10.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962
View more
  2 in total

Review 1.  Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.

Authors:  Alain E Andrea; Andrada Chiron; Sarah Mallah; Stéphanie Bessoles; Guillaume Sarrabayrouse; Salima Hacein-Bey-Abina
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

2.  CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.

Authors:  Michele Lai; Eyal Maori; Paola Quaranta; Giulia Matteoli; Fabrizio Maggi; Marco Sgarbanti; Stefania Crucitta; Simone Pacini; Ombretta Turriziani; Guido Antonelli; Jonathan L Heeney; Giulia Freer; Mauro Pistello
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.